Loading
NYSEHealthcareMedical - Healthcare Information Services
Latest quote
$10.94
−$0.16 · -1.44%
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
Previous close
$10.94
−$0.16 · -1.44%
Regular session · ET · Market data may be delayed.
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
Day range
Current $10.94
52-week range
Current $10.94
Regular session · ET · Market data may be delayed.
AI-powered factor overview
GoAI Score
Hold
Wait — insufficient conviction to act
Valuation
62
Undervalued
Sentiment
60
Mixed
Risk
64
High Risk
Momentum
32
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
Day range
Current $10.94
52-week range
Current $10.94
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 480.59M USD | 419.81M USD | 356.3M USD | 280.91M USD | 213.23M USD |
| Cost of goods sold | 154.12M USD | 134.93M USD | 124.01M USD | 109.27M USD | 81.39M USD |
| Gross profit | 326.47M USD | 284.88M USD | 232.29M USD | 171.64M USD | 131.85M USD |
| Research and development | 121.48M USD | 117.36M USD | 112.35M USD | 91.24M USD | 52.27M USD |
| Selling, general, and administrative | 180.15M USD | 197.73M USD | 226.93M USD | 231.65M USD | 175.1M USD |
| Operating expenses | 333.08M USD | 342.98M USD | 368.77M USD | 348.2M USD | 248.66M USD |
| Interest income | 2.17M USD | 2.68M USD | 4.07M USD | 2.48M USD | 79K USD |
| Interest expense | 6.95M USD | 2.35M USD | 1.85M USD | 1.41M USD | 1.16M USD |
| Depreciation and amortization | 31.45M USD | 27.89M USD | 30.54M USD | 28.77M USD | 24.52M USD |
| Operating income | −6.61M USD | −58.1M USD | −136.48M USD | −176.55M USD | −116.82M USD |
| Net income | 2.31M USD | −58.53M USD | −136.89M USD | −176.15M USD | −118.16M USD |
Company facts updated Sep 6, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
Third-party consensus; not a GoAI recommendation.
Average target
$12.00
9.69% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI19.71M0.00%2.3T USD0.03%$379.73-0.32%
iShares Russell 2000 ETFIWM15.4M0.02%79.88B USD0.19%$296.01+0.28%
Vanguard Extended Market ETFVXF7.23M0.01%93.7B USD0.05%$242.66+0.14%
Fidelity Enhanced Small Cap ETFFESM5.45M0.08%6.03B USD0.28%$47.36+0.21%
iShares Russell 2000 Growth ETFIWO4.53M0.03%14.58B USD0.24%$377.54+0.12%
VictoryShares Small Cap Free Cash Flow ETFSFLO3.58M0.42%851.61M USD0.56%$39.93-1.07%
Schwab U.S. Small-Cap ETFSCHA3.11M0.01%22.56B USD0.03%$34.55+1.01%
Vanguard Russell 2000 ETFVTWO2.97M0.02%17.4B USD0.06%$119.62+0.25%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFFidelity Enhanced Small Cap ETFFESMiShares Russell 2000 Growth ETFIWOVictoryShares Small Cap Free Cash Flow ETFSFLOSchwab U.S. Small-Cap ETFSCHAVanguard Russell 2000 ETFVTWOAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
